Testing an AI care companion tool for adults with diabetes or high blood pressure
Tests an AI care companion tool in adults with diabetes or hypertension.
Key facts
- Who runs it
- Fitbit LLC
- Where
- Portland, United StatesSee the site
- Trial code
- Registry title
- Care COMPASS Study
- Status
- Not yet recruiting
- People taking part
- 200 people, planned
- Started
- 22 Oct 2026
- Expected to end
- 30 Jul 2027
- Type of study
- Interventional
- Treatments tested
- Guide My Care Tool
- Record updated
- 29 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with type 1 or type 2 diabetes and/or high blood pressure who go to outpatient clinic visits. It tests an AI Care Companion tool.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Existing diagnosis of type 1 or type 2 diabetes and/or hypertension, with at least two outpatient visits in the past 12 months.
- Earlier treatment
- Must not have joined a health coaching trial now or in the last 6 months.
Main reasons for not taking part
- Emergency or acute medical problem at the scheduled appointment
- Pregnancy (self-reported or from medical records)
- Already took part in this study
- In a health coaching trial now or in the last 6 months
- Any other condition or reason that the study doctor decides may affect taking part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Age: Legal adult (18+)
- Existing diagnosis of Diabetes Mellitus Type 1 / 2 and/or hypertension who have had at least two outpatient visits in the prior 12 months
- Scheduled in-person clinician appointment for follow up of Diabetes Mellitus -----Type 1 / 2 and/or hypertension within the next 4 months
- Anticipate ongoing care with their current clinic for at least one month following their clinic visit for this research study
- Able to contact their health care team as needed (by telephone, messaging or other) in the 2 weeks following their clinic visit
- Able to read and write in English
- Has an active patient portal account
- Current user of smart phones
- Access to wifi or internet
Who cannot take part
- Any other medical condition or other reason- as determined by the principal investigator or designee - that may affect participant involvement, study procedures or data collection
- Patients with emergency or acute medical issues arising at their scheduled appointment
- Pregnancy (based on self-report or medical records),
- Participants who have already participated in this study
- Participating currently (or in the last 6 months) with a clinical trial of a health coaching intervention
Where in United States
- Oregon Health Sciences UniversityPortland, United StatesContact: Jeffrey Gold, MDNot yet recruiting
About the trial
What the trial wants to find out
This is a prospective, single-arm, mixed-methods pilot study at a single academic medical center to observe the impact, feasibility and acceptability of an AI Care Companion tool on activation and confidence among patients with chronic disease attending outpatient care.
The group in the trial
- Guide My Care ToolTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Care COMPASS Study: (Care Companion for Patient Activation and Self-Support)
- Plain-language title
- Testing an AI care companion tool for adults with diabetes or high blood pressureGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 13 November 2026.
- Record updated
- 29 October 2026